Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' was removed. This denotes a newer revision of the study record and acts as metadata rather than content changes.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe study page now shows Revision: v3.5.3. This indicates an updated revision of the study documents.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.5.2 has been added to the page, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check108 days agoChange DetectedRevision: v3.4.2 is now shown and prior revision notices (v3.4.1) as well as the government funding status notice are no longer displayed. These maintenance-related changes do not affect the study details or how users interact with the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.